Literature DB >> 18582794

Predictors of Survival in COPD: more than just the FEV1.

Bartolome R Celli1, Claudia G Cote, Suzanne C Lareau, Paula M Meek.   

Abstract

Chronic obstructive pulmonary disease (COPD) ranks fourth as a cause of death in the United States, behind heart disease, cancer, and stroke. Additionally, since serious co-morbidities are often present in patients with COPD, many die from other diseases such as cardiac disease or cancer. Not surprisingly, multiple factors, reflective of both respiratory disease process and the substantial co-morbidity, predict survival in the disease. As might be expected, physiologic derangements such as airflow obstruction, hypoxemia, lung hyperinflation, and exercise capacity predict survival in COPD. Anemia, cachexia and reductions in lean body mass also relate to prognosis. Perhaps less recognized is the more recent documentation that more subjective assessments, such as dyspnea and health related quality of life, are also important predictors of survival. The integration of some of the most important of these variables may provide a more comprehensive evaluation of disease severity. For example, a validated multi-dimensional disease rating that includes the body mass index (B), degree of airflow obstruction (O), dyspnea (D), and exercise capacity (E) (BODE Index) is capable of predicting COPD-related hospitalization and mortality more than its individual components.

Entities:  

Mesh:

Year:  2008        PMID: 18582794     DOI: 10.1016/S0954-6111(08)70005-2

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  37 in total

1.  Factors associated with mortality in patients with exacerbation of chronic obstructive pulmonary disease hospitalized in General Medicine departments.

Authors:  Bernardino Roca; Pedro Almagro; Francisco López; Francisco J Cabrera; Lorena Montero; David Morchón; Jesús Díez; Fernando de la Iglesia; Mario Fernández; Jesús Castiella; Elena Zubillaga; Jesús Recio; Joan B Soriano
Journal:  Intern Emerg Med       Date:  2010-10-01       Impact factor: 3.397

2.  JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia.

Authors:  Elena Bresciani; Laura Rizzi; Laura Molteni; Monica Ravelli; Antonella Liantonio; Khoubaib Ben Haj Salah; Jean-Alain Fehrentz; Jean Martinez; Robert J Omeljaniuk; Giuseppe Biagini; Vittorio Locatelli; Antonio Torsello
Journal:  Endocrine       Date:  2016-11-28       Impact factor: 3.633

Review 3.  Six-Minute Walk Test: Clinical Role, Technique, Coding, and Reimbursement.

Authors:  Priya Agarwala; Steve H Salzman
Journal:  Chest       Date:  2019-11-02       Impact factor: 9.410

Review 4.  Chronic obstructive pulmonary disease classification, phenotypes and risk assessment.

Authors:  Prasad Manian
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

5.  Relationship between sniff nasal inspiratory pressure and BODE index in patients with COPD.

Authors:  Leila Donária; Rafael Mesquita; Larissa Martinez; Luciana Sípoli; Josiane Marques Felcar; Vanessa Suziane Probst; Nidia Aparecida Hernandes; Fabio Pitta
Journal:  Lung       Date:  2014-10-01       Impact factor: 2.584

6.  Rhinosinusitis in COPD: symptoms, mucosal changes, nasal lavage cells and eicosanoids.

Authors:  Violetta M Piotrowska; Wojciech J Piotrowski; Zofia Kurmanowska; Jerzy Marczak; Paweł Górski; Adam Antczak
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-06-03

7.  Does mild COPD affect prognosis in the elderly?

Authors:  Claudio Pedone; Simone Scarlata; Claudio Sorino; Francesco Forastiere; Vincenzo Bellia; Raffaele Antonelli Incalzi
Journal:  BMC Pulm Med       Date:  2010-06-07       Impact factor: 3.317

8.  Discriminant validity of the Hospital Anxiety and Depression Scale, Beck Depression Inventory (II) and Beck Anxiety Inventory to confirmed clinical diagnosis of depression and anxiety in patients with chronic obstructive pulmonary disease.

Authors:  Tina Phan; Owen Carter; Claire Adams; Grant Waterer; Li Ping Chung; Maxine Hawkins; Cobie Rudd; Mel Ziman; Natalie Strobel
Journal:  Chron Respir Dis       Date:  2016-03-03       Impact factor: 2.444

9.  Cognitive behavioural therapy (CBT) for patients with chronic lung disease and psychological comorbidities undergoing pulmonary rehabilitation.

Authors:  Marsus I Pumar; Mark Roll; Pamela Fung; Tricia A Rolls; James R Walsh; Rayleen V Bowman; Kwun M Fong; Ian A Yang
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

Review 10.  Insights into interventions in managing COPD patients: lessons from the TORCH and UPLIFT studies.

Authors:  Marc Miravitlles; Antonio Anzueto
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.